Aurora Cannabis Inc. (NASDAQ:ACB – Free Report) – Analysts at Atb Cap Markets reduced their FY2028 earnings per share (EPS) estimates for shares of Aurora Cannabis in a report released on Wednesday, November 5th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings per share of $0.07 for the year, down from their previous forecast of $0.15. The consensus estimate for Aurora Cannabis’ current full-year earnings is $0.46 per share. Atb Cap Markets also issued estimates for Aurora Cannabis’ FY2029 earnings at $0.29 EPS.

Aurora Cannabis (NASDAQ:ACB – Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.03 by $0.06. The company had revenue of $64.88 million during the quarter, compared to analyst estimates of $86.45 million. Aurora Cannabis had a negative return on equity of 0.57% and a negative net margin of 15.96%.

ACB has been the subject of a number of other reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aurora Cannabis in a report on Wednesday, October 8th. Zacks Research raised Aurora Cannabis from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Finally, Wall Street Zen lowered Aurora Cannabis from a “hold” rating to a “sell” rating in a research report on Friday, July 18th. Two investment analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy”.

View Our Latest Research Report on Aurora Cannabis

Aurora Cannabis Price Performance

Aurora Cannabis stock traded up $0.08 during mid-day trading on Friday, hitting $4.44. 667,272 shares of the company traded hands, compared to its average volume of 1,829,352. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.51 and a current ratio of 2.97. Aurora Cannabis has a one year low of $3.42 and a one year high of $6.91. The stock has a market cap of $249.79 million, a price-to-earnings ratio of -6.46 and a beta of 1.71. The stock has a fifty day moving average price of $5.21 and a 200-day moving average price of $5.00.

Hedge Funds Weigh In On Aurora Cannabis

A number of hedge funds have recently bought and sold shares of ACB. DKM Wealth Management Inc. purchased a new position in Aurora Cannabis in the 2nd quarter worth approximately $42,000. JW Asset Management LLC bought a new stake in Aurora Cannabis during the first quarter valued at approximately $58,000. Headlands Technologies LLC bought a new position in Aurora Cannabis in the 2nd quarter worth $66,000. Engineers Gate Manager LP purchased a new position in shares of Aurora Cannabis during the 2nd quarter valued at about $68,000. Finally, Wealthcare Advisory Partners LLC bought a new position in shares of Aurora Cannabis in the third quarter worth approximately $81,000. Institutional investors own 47.63% of the company’s stock.

About Aurora Cannabis

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Aurora Cannabis, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Aurora Cannabis wasn’t on the list.

While Aurora Cannabis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here